EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Cerebral tau pathology in cerebral amyloid angiopathy

Hsin-Hsi Tsai iD, Chia-Ju Liu, Bo-Ching Lee, Ya-Fang Chen, Ruoh-Fang Yen, Jiann-Shing Jeng, Li-Kai Tsai

Brain Communications · 2024-03-01 · 6 (2)

DOI: 10.1093/braincomms/fcae086 ↗

At a glance

Journal article in Brain Communications, published online on 2024-03-12. Written by Hsin-Hsi Tsai and 6 co-authors. Institution: Department of Neurology, National Taiwan University Hospital, Taipei 100225, Taiwan. Cited 17 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY 4.0). Funded by: Taiwan National Science and Technology Council, National Taiwan University Hospital.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Tau, a hallmark of Alzheimer’s disease, is poorly characterized in cerebral amyloid angiopathy. We aimed to assess the clinico-radiological correlations between tau positron emission tomography scans and cerebral amyloid angiopathy. We assessed cerebral amyloid and hyperphosphorylated tau in patients with probable cerebral amyloid angiopathy (n = 31) and hypertensive small vessel disease (n = 27) using 11C-Pittsburgh compound B and 18F-T807 positron emission tomography. Multivariable regression models were employed to assess radio-clinical features related to cerebral tau pathology in cerebral amyloid angiopathy. Cerebral amyloid angiopathy exhibited a higher cerebral tau burden in the inferior temporal lobe [1.25 (1.17–1.42) versus 1.08 (1.05–1.22), P < 0.001] and all Braak stage regions of interest (P < 0.05) than hypertensive small vessel disease, although the differences were attenuated after age adjustment. Cerebral tau pathology was significantly associated with cerebral amyloid angiopathy-related vascular markers, including cortical superficial siderosis (β = 0.12, 95% confidence interval 0.04–0.21) and cerebral amyloid angiopathy score (β = 0.12, 95% confidence interval 0.03–0.21) after adjustment for age, ApoE4 status and whole cortex amyloid load. Tau pathology correlated significantly with cognitive score (Spearman’s ρ=−0.56, P = 0.001) and hippocampal volume (−0.49, P = 0.007), even after adjustment. In conclusion, tau pathology is more frequent in sporadic cerebral amyloid angiopathy than in hypertensive small vessel disease. Cerebral amyloid angiopathy-related vascular pathologies, especially cortical superficial siderosis, are potential markers of cerebral tau pathology suggestive of concomitant Alzheimer’s disease.

Subjects

Author keywords

Alzheimer’s diseasecerebral amyloid angiopathycortical superficial siderosisintracerebral haemorrhagesmall vessel disease

Authors and institutions

  • Department of Neurology, National Taiwan University Hospital, Taipei 100225, Taiwan.
  • Department of Nuclear Medicine, National Taiwan University Hospital, Taipei 100225, Taiwan.
  • Department of Medical Imaging, National Taiwan University Hospital, Taipei 100225, Taiwan.

ORCID profiles: Hsin-Hsi Tsai

Funding

  • Taiwan National Science and Technology Council
  • National Taiwan University Hospital

Cite

APA

Tsai, H. H., Liu, C. J., Lee, B. C., Chen, Y. F., Yen, R. F., Jeng, J. S., & Tsai, L. K. (2024). Cerebral tau pathology in cerebral amyloid angiopathy. Brain Communications, 6(2). https://doi.org/10.1093/braincomms/fcae086

Vancouver

Tsai HH, Liu CJ, Lee BC, Chen YF, Yen RF, Jeng JS, et al. Cerebral tau pathology in cerebral amyloid angiopathy. Brain Communications. 2024;6(2). doi:10.1093/braincomms/fcae086

BibTeX
@article{Tsai2024,
  author = {Tsai, Hsin-Hsi and Liu, Chia-Ju and Lee, Bo-Ching and Chen, Ya-Fang and Yen, Ruoh-Fang and Jeng, Jiann-Shing and Tsai, Li-Kai},
  title = {Cerebral tau pathology in cerebral amyloid angiopathy},
  journal = {Brain Communications},
  year = {2024},
  volume = {6},
  number = {2},
  doi = {10.1093/braincomms/fcae086}
}
Start for free →